Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Assets (2020 - 2026)

Journey Medical filings provide 6 years of Assets readings, the most recent being $94.6 million for Q4 2025.

  • On a quarterly basis, Assets rose 17.88% to $94.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.6 million, a 17.88% increase, with the full-year FY2025 number at $94.6 million, up 17.88% from a year prior.
  • Assets hit $94.6 million in Q4 2025 for Journey Medical, up from $85.2 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $120.9 million in Q1 2022 to a low of $64.0 million in Q3 2024.
  • Median Assets over the past 5 years was $85.1 million (2025), compared with a mean of $86.9 million.
  • Biggest five-year swings in Assets: surged 87.42% in 2021 and later tumbled 39.05% in 2023.
  • Journey Medical's Assets stood at $97.3 million in 2021, then increased by 8.1% to $105.2 million in 2022, then decreased by 26.92% to $76.8 million in 2023, then grew by 4.41% to $80.2 million in 2024, then grew by 17.88% to $94.6 million in 2025.
  • The last three reported values for Assets were $94.6 million (Q4 2025), $85.2 million (Q3 2025), and $81.2 million (Q2 2025) per Business Quant data.